S 3388 New Jersey Senate · 2024-2025 Regular Session

Allows pharmacists to transfer Schedule II attention-deficit/hyperactivity disorder prescriptions.

This bill allows pharmacists in New Jersey to transfer Schedule II prescriptions for attention-deficit/hyperactivity disorder (ADHD) medications between pharmacies, directly affecting patients who need these medications. Currently, patients must obtain a new prescription from their doctor if a pharmacy cannot fill an ADHD prescription; this bill enables direct pharmacy-to-pharmacy transfers instead. The transfer must comply with federal regulations and applies only to ADHD prescriptions for Schedule II drugs (stronger medications like Adderall), not all Schedule II substances. This change aims to improve access during medication shortages and reduce patient wait times.
Bill status signed all 5 stages cleared
Introduction
Jun 2024
Committee Review
Feb 2025
Senate Passage
Feb 2025
General Assembly Passage
Feb 2025
Signed into Law
Apr 2025
Introduced Jun 6, 2024 Signed Apr 22, 2025
Floor votes · Senate Feb 25, 2025 · General Assembly Feb 27, 2025

How they voted

380
Passed · 2 other
Total votes 40
Feb 25, 2025
D Democratic25
23 Yea 2
92% Yea
R Republican15
15 Yea
100% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
7
Key actions
4
Committee
1
Apr 22, 2025
Signed into law
Approved P.L.2025, c.45.
executive
Feb 27, 2025
Lower · Passed
Passed Assembly (Passed Both Houses) (75-0-0)
lower
Feb 25, 2025
Upper · Passed
Passed Senate (38-0)
upper
Feb 10, 2025
Upper · Passed
Reported out of Senate Committee, 2nd Reading
upper
Jun 6, 2024
Introduced
Introduced in the Senate, Referred to Senate Commerce Committee
upper
5 primary · 7 co-sponsors

Sponsors